Literature DB >> 9338786

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis.

H Groux1, A O'Garra, M Bigler, M Rouleau, S Antonenko, J E de Vries, M G Roncarolo.   

Abstract

Induction and maintenance of peripheral tolerance are important mechanisms to maintain the balance of the immune system. In addition to the deletion of T cells and their failure to respond in certain circumstances, active suppression mediated by T cells or T-cell factors has been proposed as a mechanism for maintaining peripheral tolerance. However, the inability to isolate and clone regulatory T cells involved in antigen-specific inhibition of immune responses has made it difficult to understand the mechanisms underlying such active suppression. Here we show that chronic activation of both human and murine CD4+ T cells in the presence of interleukin (IL)-10 gives rise to CD4+ T-cell clones with low proliferative capacity, producing high levels of IL-10, low levels of IL-2 and no IL-4. These antigen-specific T-cell clones suppress the proliferation of CD4+ T cells in response to antigen, and prevent colitis induced in SCID mice by pathogenic CD4+CD45RB(high) splenic T cells. Thus IL-10 drives the generation of a CD4+ T-cell subset, designated T regulatory cells 1 (Tr1), which suppresses antigen-specific immune responses and actively downregulates a pathological immune response in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9338786     DOI: 10.1038/39614

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  911 in total

Review 1.  Cytokines in experimental colitis.

Authors:  P Garside
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

Review 2.  Anti-TNF antibody treatment of Crohn's disease.

Authors:  S J van Deventer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 3.  T-cell reactivity to beta-cell antigens in human insulin-dependent (type 1) diabetes mellitus. Implications for diagnosis and therapy.

Authors:  B O Roep
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 4.  Immune mechanisms that regulate susceptibility to autoimmune type I diabetes.

Authors:  B Singh; T L Delovitch
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 5.  Routes to allograft survival.

Authors:  J S Bromberg; B Murphy
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 6.  Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

Authors:  M Vukmanovic-Stejic; M J Thomas; A Noble; D M Kemeny
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

7.  Competition for antigenic sites during T cell proliferation: a mathematical interpretation of in vitro data.

Authors:  J A Borghans; L S Taams; M H Wauben; R J de Boer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

Review 8.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

9.  Cytokine mRNA expression in mucosal biopsies from German shepherd dogs with small intestinal enteropathies.

Authors:  A J German; C R Helps; E J Hall; M J Day
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

10.  Cytokines and the regulation of tolerance.

Authors:  J L Ferrara
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.